Caterina Brindicci

As Senior Vice President & Global Head Research and Development, Respiratory & Immunology, I work end-to-end from pre-clinical discovery research through to Phase III, regulatory submission, approval, and subsequently into life cycle management. I have the pleasure of leading a global team of +900 inspirational scientists, biometrics experts, and regulatory affairs specialists.

Despite important advances in recent years, there continues to be significant unmet need across respiratory and immunology diseases – from conditions like asthma and COPD affecting millions across the globe, to rare diseases with limited treatment options.

I joined AstraZeneca in 2022 and have been struck by the outstanding commitment to pushing the boundaries of science to transform care for people living with respiratory and immunology-based diseases. Our ambition is to transform Respiratory & Immunology care for patients, moving beyond symptom control to disease modification, remission and, one day, cure. Science thrives in a culture of collaboration, so I am so pleased to see the innovative partnerships at play, within AstraZeneca and externally, to help us realise this ambition.